MedPath

DALMACOL

DALMACOL

Approved
DIN Number

02230769

Drug Class

Human

Market Date

Mar 26, 1997

Company
HC

laboratoire riva inc.

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02230769
AIG Number0514272001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Narcotic (CDSA I)
A
ATC Code
R05DA20 COMBINATIONS
Product Specifications
Dosage FormSyrup
Route of AdministrationOral
AHFS Classification48:08.00
Health Canada Classification

ACTIVE INGREDIENTS (5)

ALCOHOL ANHYDROUSActive
Strength: 0.25 ML / 5 ML
Monograph: ALCOHOL ANHYDROUS
DOXYLAMINE SUCCINATEActive
Strength: 6 MG / 5 ML
Monograph: DOXYLAMINE SUCCINATE
ETAFEDRIN HYDROCHLORIDEActive
Strength: 16.65 MG / 5 ML
Monograph: ETAFEDRIN HYDROCHLORIDE
HYDROCODONE BITARTRATEActive
Strength: 1.65 MG / 5 ML
Monograph: HYDROCODONE BITARTRATE
SODIUM CITRATEActive
Strength: 200 MG / 5 ML
Monograph: SODIUM CITRATE

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.